ALT
Altimmune, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.23
+1.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 23.46x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.91x
- Price / sales
- —
- Price / cash flow
- -5.67x
Enterprise value
- Enterprise value
- $143.2M
- EV / sales
- 4619.27x
- EV / EBITDA
- -1.55x
- EV / EBIT
- -1.43x
- Market cap
- $433.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026